Explain this page
Arphra AIPlain-English read on Edwards Lifesciences Corporation’s valuationCompany profile
DB · companies + sec_company_profileEdwards Lifesciences Corporation (EW) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolEW
- Legal nameEdwards Lifesciences Corporation
- SectorHealthcare
- IndustryMedical - Devices
- CountryUS
- CurrencyUSD
- ExchangeNYSE
- CIK0001099800
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$48.42B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge FMP, SEC, and non-US data.
- FIGIBBG000BRXP69
- CountryUSA
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Bernard J. Zovighian | Chief Executive Officer & Director | $3.79M | 1968 | — |
| Scott Ullem | Corporate Vice President & Chief Financial Officer | $1.85M | 1967 | — |
| Annette Maria Bruls | Corporate Vice President of EMEA, Canada, & Latin America | $1.63M | 1971 | — |
| Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development | $1.6M | 1962 | — |
| Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies | $1.56M | 1979 | — |
| Jean-Luc Lemercier | Corporate Vice President of Japan, Asia Pacific & Greater China | $1.43M | 1957 | — |
| Todd Brinton FACC | Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer | — | — | — |
| Dirksen J. Lehman | Corporate Vice President of Public Affairs | — | — | — |